SETTING: A tuberculosis (TB) case contact study in the Gambia. OBJECTIVE: To test whether Mycobacterium africanum, which has lost around 68 kb compared with M. tuberculosis sensu stricto, causes less severe TB disease. DESIGN: We genotyped mycobacterial isolates and compared clinical and radiological characteristics as well as outcome data of M. africanum-infected TB patients with those infected with M. tuberculosis. RESULTS: Of 317 index cases, 301 had a mycobacterial isolate available, 290 of which had an interpretable spoligotype pattern. Of these, 110 isolates (38%) were M. africanum and 180 (62%) were M. tuberculosis. M. africanum cases had lower body mass indices (17 vs. 17.45 for M. tuberculosis-infected patients, P = 0.029) and their radiographic disease was more extensive (96% vs. 89% had at least moderately severe radiographic changes, P = 0.031). Outcome on treatment was similar (2.8% of human immunodeficiency virus [HIV] negative M. africanum patients died on treatment vs. 3.0% of M. tuberculosis patients, P = 0.95). CONCLUSION: M. africanum causes sputum smear-positive tuberculosis disease that is at least as severe as that caused by M. tuberculosis sensu stricto. Further clinical comparisons may be helpful in smear-negative patients and HIV-TB co-infected patients, and to identify whether there is any difference in time to develop disease.
SETTING: A tuberculosis (TB) case contact study in the Gambia. OBJECTIVE: To test whether Mycobacterium africanum, which has lost around 68 kb compared with M. tuberculosis sensu stricto, causes less severe TB disease. DESIGN: We genotyped mycobacterial isolates and compared clinical and radiological characteristics as well as outcome data of M. africanum-infected TB patients with those infected with M. tuberculosis. RESULTS: Of 317 index cases, 301 had a mycobacterial isolate available, 290 of which had an interpretable spoligotype pattern. Of these, 110 isolates (38%) were M. africanum and 180 (62%) were M. tuberculosis. M. africanum cases had lower body mass indices (17 vs. 17.45 for M. tuberculosis-infected patients, P = 0.029) and their radiographic disease was more extensive (96% vs. 89% had at least moderately severe radiographic changes, P = 0.031). Outcome on treatment was similar (2.8% of human immunodeficiency virus [HIV] negative M. africanum patients died on treatment vs. 3.0% of M. tuberculosis patients, P = 0.95). CONCLUSION: M. africanum causes sputum smear-positive tuberculosis disease that is at least as severe as that caused by M. tuberculosis sensu stricto. Further clinical comparisons may be helpful in smear-negative patients and HIV-TB co-infected patients, and to identify whether there is any difference in time to develop disease.
Authors: Bourahima Kone; Anou M Somboro; Jane L Holl; Bocar Baya; Antieme Acg Togo; Yeya Dit Sadio Sarro; Bassirou Diarra; Ousmane Kodio; Robert L Murphy; William Bishai; Mamoudou Maiga; Seydou Doumbia Journal: Int J Mol Epidemiol Genet Date: 2020-06-15
Authors: Bouke C de Jong; Ifedayo Adetifa; Brigitte Walther; Philip C Hill; Martin Antonio; Martin Ota; Richard A Adegbola Journal: FEMS Immunol Med Microbiol Date: 2009-11-03
Authors: Michael B Reed; Victoria K Pichler; Fiona McIntosh; Alicia Mattia; Ashley Fallow; Speranza Masala; Pilar Domenech; Alice Zwerling; Louise Thibert; Dick Menzies; Kevin Schwartzman; Marcel A Behr Journal: J Clin Microbiol Date: 2009-02-11 Impact factor: 5.948
Authors: Sidra E Gonçalves Vasconcellos; Richard C Huard; Stefan Niemann; Kristin Kremer; Adalberto R Santos; Philip N Suffys; John L Ho Journal: BMC Infect Dis Date: 2010-03-29 Impact factor: 3.090
Authors: Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry Journal: Infect Immun Date: 2013-05-28 Impact factor: 3.441
Authors: Noel H Smith; R Glyn Hewinson; Kristin Kremer; Roland Brosch; Stephen V Gordon Journal: Nat Rev Microbiol Date: 2009-06-01 Impact factor: 60.633
Authors: Bouke C de Jong; Martin Antonio; Timothy Awine; Kunle Ogungbemi; Ype P de Jong; Sebastien Gagneux; Kathryn DeRiemer; Thierry Zozio; Nalin Rastogi; Martien Borgdorff; Philip C Hill; Richard A Adegbola Journal: J Clin Microbiol Date: 2009-02-04 Impact factor: 5.948
Authors: Bouke C de Jong; Abdulrahman Hammond; Jacob K Otu; Martin Antonio; Richard A Adegbola; Martin O Ota Journal: BMC Infect Dis Date: 2010-01-19 Impact factor: 3.090